GSC
GILD icon

Ground Swell Capital’s Gilead Sciences GILD Stock Holding History

Ground Swell Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,440
Closed -$493K – 126
2025
Q3 		$493K Buy
+4,440
New +$505K 1.08% 30
2023
Q4 		– Sell
-3,539
Closed -$265K – 88
2023
Q3 		$265K Buy
+3,539
New +$272K 0.43% 31
2022
Q4 		– Sell
-12,497
Closed -$771K – 101
2022
Q3 		$771K Buy
12,497
+5,558
+80% +$350K 2.19% 13
2022
Q2 		$429K Buy
+6,939
New +$430K 0.79% 32
2014
Q3 		$271K Buy
2,547
+825
+48% +$80.8K 0.51% 26
2014
Q2 		$143K Buy
+1,722
New +$134K 0.28% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ground Swell Capital's GILD Position: Q4 2025 in Review

Ground Swell Capital sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 4,440 shares — an estimated $493K sold.

Ground Swell Capital first reported a position in GILD in Q2 2014 and held it in 6 quarters. The position peaked at $771K in Q3 2022. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Ground Swell Capital reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Ground Swell Capital sold 4,440 Gilead Sciences shares in Q4 2025, an estimated $493K.
  • Ground Swell Capital first reported a position in Gilead Sciences in Q2 2014 and held it in 6 quarters.
  • Ground Swell Capital's Gilead Sciences position peaked at $771K in Q3 2022.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Ground Swell Capital's 13F filing for Q4 2025, filed 4 Feb 2026.